# Short Contact Protocols to Reduce Pain During 10% ALA Gel Red-light Photodynamic Therapy of Actinic Keratoses

> **NCT06027619** · PHASE2 · COMPLETED · sponsor: **Case Comprehensive Cancer Center** · enrollment: 30 (actual)

## Conditions studied

- Actinic Keratosis

## Interventions

- **DRUG:** Topical aminolevulinate (10% ALA gel)
- **DEVICE:** Red light illumination

## Key facts

- **NCT ID:** NCT06027619
- **Lead sponsor:** Case Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-10-02
- **Primary completion:** 2024-07-08
- **Final completion:** 2024-07-08
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2025-10-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06027619

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06027619, "Short Contact Protocols to Reduce Pain During 10% ALA Gel Red-light Photodynamic Therapy of Actinic Keratoses". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06027619. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*